Leukos Biotech is a biopharmaceutical company focused on the development of new treatments for Acute Myeloid Leukaemia and other haematological malignancies. The company was founded in 2015 as a spin-off from the Josep Carreras Leukaemia Research Institute (IJC) and has a strong scientific, institutional and economic support from the IJC and the Josep Carreras Leukaemia Foundation, among other partners and collaborators.